Folia Biologica
Journal of Cellular and Molecular Biology, Charles University 

Crossref logo

Fol. Biol. 2014, 60, 228-234

https://doi.org/10.14712/fb2014060050228

Mycophenolate Mofetil and Cyclophosphamide Treatments Suppress Inflammation Intensity in an Experimental Model of Autoimmune Uveitis

Aneta Klímová1, P. Seidler Štangová1, J. Heissigerová1, P. Svozílková1, T. Kučera2

1Department of Ophthalmology, First Faculty of Medicine, Charles University in Prague and General University Hospital in Prague, Czech Republic
2Institute of Histology and Embryology, First Faculty of Medicine, Charles University in Prague, Czech Republic

Received March 2014
Accepted May 2014

References

1. Avichezer, D., Silver, P. B., Chan, C. C., Wiggert, B., Caspi, R. R. (2000) Identification of a new epitope of human IRBP that induces autoimmune uveoretinitis in mice of the H-2b haplotype. Invest. Ophthalmol. Vis. Sci. 41, 127-131.
2. Broderick, C., Hoek, R. M., Forrester, J. V., Liversidge, J., Sedgwick, J. D., Dick, A. D. (2002) Constitutive retinal CD200 expression regulates resident microglia and activation state of inflammatory cells during experimental autoimmune uveoretinitis. Am. J. Pathol. 161, 1669-1677. <https://doi.org/10.1016/S0002-9440(10)64444-6>
3. Caspi, R. R., Roberge, F. G., Chan, C. C., Wiggert, B., Chader, G. J., Rozenszajn, L. A., Lando, Z., Nussenblatt, R. B. (1988) A new model of autoimmune disease. Experimental autoimmune uveoretinitis induced in mice with two different retinal antigens. J. Immunol. 140, 1490-1495. <https://doi.org/10.4049/jimmunol.140.5.1490>
4. Caspi, R. R., Chan, C. C., Wiggert, B., Chader, G. J. (1990a) The mouse as a model of experimental autoimmune uveoretinitis (EAU). Curr. Eye Res. 9 (Suppl), 169-174. <https://doi.org/10.3109/02713689008999438>
5. Caspi, R. R., Chan, C. C., Leake, W. C., Higuchi, M., Wiggert, B., Chader, G. J. (1990b) Experimental autoimmune uveoretinitis in mice. Induction by a single eliciting event and dependence on quantitative parameters of immunization. J. Autoimmun. 3, 237-246. <https://doi.org/10.1016/0896-8411(90)90143-G>
6. Chanaud, N. P., Vistica, B. P., Eugui, E., Nussenblatt, R. B., Allison, A. C., Gery, I. (1995) Inhibition of experimental autoimmune uveoretinitis by mycophenolate mofetil, an inhibitor of purine metabolism. Exp. Eye Res. 61, 429-434. <https://doi.org/10.1016/S0014-4835(05)80138-1>
7. Daniel, E., Thorne, J. E., Newcomb, C. W., Pujari, S. S., Kaçmaz, R. O., Levy-Clarke, G. A., Nussenblatt, R. B., Rosenbaum, J. T., Suhler, E. B., Foster, C. S., Jabs, D. A., Kempen, J. H. (2010) Mycophenolate mofetil for ocular inflammation. Am. J. Ophthalmol. 149, 423-432.e1-2. <https://doi.org/10.1016/j.ajo.2009.09.026>
8. Dick, A. D., Cheng, Y. F., Liversidge, J., Forrester, J. V. (1994) Immunomodulation of experimental autoimmune uveoretinitis: a model of tolerance induction with retinal antigens. Eye (Lond), 8 (Pt 1), 52-59. <https://doi.org/10.1038/eye.1994.10>
9. Dick, A. D., Kreutzer, B., Laliotou, B, Forrester, J. V. (1998) Effects of mycophenolate mofetil on nasal mucosal tolerance induction. Invest. Ophthalmol. Vis. Sci. 39, 835-840.
10. Doycheva, D., Zierhut, M., Blumenstock, G., Stuebiger, N, Deuter, C. (2011) Long-term results of therapy with mycophenolate mofetil in chronic non-infectious uveitis. Graefes Arch. Clin. Exp. Ophthalmol. 249, 1235-1243. <https://doi.org/10.1007/s00417-011-1731-8>
11. Durrani, O. M., Meads, C. A., Murray, P. I. (2004) Uveitis: a potentially blinding disease. Ophthalmologica 218, 223-236. <https://doi.org/10.1159/000078612>
12. Forrester, J. V., Liversidge, J., Dua, H. S., Towler, H., McMenamin, P. G. (1990) Comparison of clinical and experimental uveitis. Curr. Eye Res. 9 (Suppl.), 75-84. <https://doi.org/10.3109/02713689008999424>
13. Forrester, J. V., Liversidge, J., Dua, H. S., Dick, A., Harper, F., McMenamin, P. G. (1992) Experimental autoimmune uveoretinitis: a model system for immunointervention: a review. Curr. Eye Res. 11 (Suppl.), 33-40. <https://doi.org/10.3109/02713689208999509>
14. Khan, I. J., Barry, R. J., Amissah-Arthur, K. N., Carruthers, D., Elamanchi, S. R., Situnayake, D., Murray, P. I., Denniston, A. K., Rauz, S. (2013) Ten-year experience of pulsed intravenous cyclophosphamide and methylprednisolone protocol (PICM protocol) in severe ocular inflammatory disease. Br. J. Ophthalmol. 97, 1118-1122. <https://doi.org/10.1136/bjophthalmol-2012-302130>
15. Miserocchi, E., Modorati, G., Pontikaki, I., Meroni, P. L., Gerloni, V. (2013) Long-term treatment with golimumab for severe uveitis. Ocul. Immunol. Inflamm. 22, 90-95. <https://doi.org/10.3109/09273948.2013.844265>
16. Mochizuki, M., Nussenblatt, R. B., Kuwabara, T., Gery, I. (1985) Effects of cyclosporine and other immunosuppressive drugs on experimental autoimmune uveoretinitis in rats. Invest. Ophthalmol. Vis. Sci. 26, 226-232.
17. Paques, M., Guyomard, J. L., Simonutti, M., Roux, J. M., Picaud, S., Le-Gargasson, J. F., Sahel, J. A. (2007) Panretinal, high resolution color photography of the mouse fundus. Invest. Ophthalmol. Vis. Sci. 48, 2769-2774. <https://doi.org/10.1167/iovs.06-1099>
18. Siepmann, K., Huber, M., Stübiger, N., Deuter, C., Zierhut, M. (2006) Mycophenolate mofetil is a highly effective and safe immunosuppressive agent for the treatment of uveitis: a retrospective analysis of 106 patients. Graefes Arch. Clin. Exp. Ophthalmol. 244, 788-794. <https://doi.org/10.1007/s00417-005-0066-8>
19. Suelves, A. M., Arcinue, C. A., González-Martin, J. M., Kruh, J. N., Foster, C. S. (2013) Analysis of a novel protocol of pulsed intravenous cyclophosphamide for recalcitrant or severe ocular inflammatory disease. Ophthalmology 120, 1201-1209. <https://doi.org/10.1016/j.ophtha.2013.01.031>
20. Suttorp-Schulten, M. S., Rothova, A. (1996) The possible impact of uveitis in blindness: a literature survey. Br. J. Ophthalmol. 80, 844-848. <https://doi.org/10.1136/bjo.80.9.844>
21. Suzuki, I., Takahashi, S., Fujii, Y., Fuyama, S., Arai, S. (1989) Experimental autoimmune uveoretinitis (EAU) in rats: isolation of S-antigen, EAU susceptibility of rat strains, genetic control of EAU induction, and effects of cyclophosphamide and irritation on EAU. Jpn. J. Ophthalmol. 33, 13-26.
22. Teoh, S. C., Hogan, A. C., Dick, A. D., Lee, R. W. (2008) Mycophenolate mofetil for the treatment of uveitis. Am. J. Ophthalmol. 146, 752-60. <https://doi.org/10.1016/j.ajo.2008.03.004>
23. Thurau, S.. R., Chan, C. C., Nussenblatt, R. B., Caspi, R. R. (1997) Oral tolerance in a murine model of relapsing experimental autoimmune uveoretinitis (EAU): induction of protective tolerance in primed animals. Clin. Exp. Immunol. 109, 370-376. <https://doi.org/10.1046/j.1365-2249.1997.4571356.x>
24. Xu, H., Koch, P., Chen, M., Lau, A., Reid, D. M., Forrester, J. V. (2008) A clinical grading system for retinal inflammation in the chronic model of experimental autoimmune uveoretinitis using digital fundus images. Exp. Eye Res. 87, 319-326. <https://doi.org/10.1016/j.exer.2008.06.012>
25. Zierhut, M., Stübiger, N., Siepmann, K., Deuter, C. M. (2005) MMF and eye disease. Lupus 14 (Suppl 1), 50-54. <https://doi.org/10.1191/0961203305LU2119OA>
front cover

ISSN 0015-5500 (Print) ISSN 2533-7602 (Online)

Open access journal

Submissions

Archive